Literature DB >> 17483125

Persistent ischaemic ECG abnormalities on repeated ECG examination have important prognostic value for cardiovascular disease beyond established risk factors: a population-based study in middle-aged men with up to 32 years of follow-up.

Christina Ström Möller1, Björn Zethelius, Johan Sundström, Lars Lind.   

Abstract

OBJECTIVE: To determine the effect of new, persistent or reverted ischaemic ECG abnormalities at ages 50 and 70 years on the risk of subsequent cardiovascular disease. DESIGN, SETTING AND PARTICIPANTS: A prospective community-based observational cohort of 50-year-old men in Sweden, followed for 32 years. 2322 men of age 50 years participated in 1970-3, and 1221 subjects were re-examined at the age of 70 years. MAIN OUTCOME MEASURES: Myocardial infarction (MI), cardiovascular mortality and overall mortality.
RESULTS: At 50 years of age, after adjusting for established conventional risk factors, T wave abnormalities, ST segment depression, major Q/QS pattern and ECG-left ventricular hypertrophy were all found to be independent risk factors for the main outcome measures during the 32 years of follow-up. When ECG variables were re-measured at 70 years of age, they were still found to be independent risk factors for the mortality outcomes, but lost in significance for prediction of MI. Regarding mortality, it was twice as dangerous to have persistent T wave abnormalities (HR 4.63; 95% CI 2.18 to 9.83) or ST segment depression (HR 5.66; 95% CI 1.77 to 18.1), as with new T wave abnormalities (HR 2.20; 95% CI 1.48 to 3.29) or ST segment depression (HR 2.55; 95% CI 1.74 to 3.75), developing between ages 50 and 70 years. The addition of "ECG indicating ischaemia" significantly increased the predictive power of the Framingham score (p<0.001).
CONCLUSIONS: It is worthwhile to obtain serial ECGs for proper risk assessment, since persistent ST-T abnormalities carried twice as high a risk for future mortality compared with new or reverted abnormalities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483125      PMCID: PMC1955011          DOI: 10.1136/hrt.2006.109116

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

Review 1.  The prevalence and prognostic significance of electrocardiographic abnormalities.

Authors:  E A Ashley; V K Raxwal; V F Froelicher
Journal:  Curr Probl Cardiol       Date:  2000-01       Impact factor: 5.200

2.  The electrocardiogram in population studies. A classification system.

Authors:  H BLACKBURN; A KEYS; E SIMONSON; P RAUTAHARJU; S PUNSAR
Journal:  Circulation       Date:  1960-06       Impact factor: 29.690

3.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

4.  Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers.

Authors:  J Merlo; U Lindblad; H Pessah-Rasmussen; B Hedblad; J Rastam; S O Isacsson; L Janzon; L Råstam
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

5.  The ischemic electrocardiogram: a harbinger for ischemic heart disease independent of the blood pressure level. The Copenhagen City Heart Study.

Authors:  Carsten Toftager Larsen; Henry Blackburn; Niels Eske Bruun; Gorm Boje Jensen; Henrik Scharling; Peter Schnohr
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

6.  Approved IFCC recommendation on reporting results for blood glucose (abbreviated).

Authors:  Paul D'Orazio; Robert W Burnett; Niels Fogh-Andersen; Ellis Jacobs; Katsuhiko Kuwa; Wolf R Külpmann; Lasse Larsson; Andrzej Lewenstam; Anton H J Maas; Gerhard Mager; Jerzy W Naskalski; Anthony O Okorodudu
Journal:  Clin Chem       Date:  2005-09       Impact factor: 8.327

7.  Determinants of persistent negative T waves and early versus late T wave normalisation after acute myocardial infarction.

Authors:  L A Pierard; P Lancellotti
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

8.  Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women.

Authors:  D De Bacquer; G De Backer; M Kornitzer; H Blackburn
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

9.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

10.  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Authors:  Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven Snapinn; Katherine E Harris; Peter Aurup; Jonathan M Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

View more
  3 in total

1.  Measurement of ECG abnormalities and cardiovascular risk classification: a cohort study of primary care patients in the Netherlands.

Authors:  Anne Groot; Michiel L Bots; Frans H Rutten; Hester M den Ruijter; Mattijs E Numans; Ilonca Vaartjes
Journal:  Br J Gen Pract       Date:  2015-01       Impact factor: 5.386

2.  Changes in ischaemic ECG abnormalities and subsequent risk of cardiovascular disease.

Authors:  Takeshi Sawai; Hironori Imano; Isao Muraki; Mina Hayama-Terada; Yuji Shimizu; Renzhe Cui; Akihiko Kitamura; Masahiko Kiyama; Takeo Okada; Tetsuya Ohira; Kazumasa Yamagishi; Mitsumasa Umesawa; Tomoko Sankai; Hiroyasu Iso
Journal:  Heart Asia       Date:  2017-01-23

3.  A modeling and machine learning approach to ECG feature engineering for the detection of ischemia using pseudo-ECG.

Authors:  Carlos A Ledezma; Xin Zhou; Blanca Rodríguez; P J Tan; Vanessa Díaz-Zuccarini
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.